![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1931944-80-7
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | Donanemab REF: TM-T77162CAS: 1931944-80-7 | - - - | 270,00 €~2.218,00 € | Jue 25 Jul 24 |
![]() | Donanemab REF: 3D-CLA1552CAS: 1931944-80-7 | - - - | A consultar | Mar 06 Ago 24 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Donanemab
CAS:1931944-80-7
Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.
Forma y color:
Solid
Ref: TM-T77162
1mg | 270,00 € | ||
5mg | 702,00 € | ||
10mg | 1.100,00 € | ||
25mg | 1.659,00 € | ||
50mg | 2.218,00 € |
Entrega estimada en Estados Unidos, el Jueves 25 de Julio de 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Donanemab
CAS:1931944-80-7
A humanized IgG1 monoclonal antibody targets Aβ N-terminal epitope (p3-42).
Ref: 3D-CLA1552
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 6 de Agosto de 2024